The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Primary Sclerosing Cholangitis: Diagnosis, Prognosis, and Management
Open accessAbstract
Primary sclerosing cholangitis (PSC) is a chronic immune-mediated disease of the liver of unclear etiology, characterized by chronic inflammation and fibrosis of bile ducts. It primarily affects middle-aged men and is associated with 4-fold increased mortality as compared with an age- and sex-matched population. Progressive biliary and hepatic damage results in portal hypertension and hepatic failure in a significant majority of patients over a 10- to 15-year period from the initial diagnosis. In addition, PSC confers a markedly increased risk of hepatobiliary cancer, including cholangiocarcinoma and gallbladder cancer, as compared with the general population, and cancer is the leading cause of mortality in patients with PSC. It is associated with inflammatory bowel disease in 70% of patients and increases the risk of colorectal cancer almost 10-fold. Despite significant research efforts in this field, the pathogenic mechanisms of PSC are still incompletely understood, although growing evidence supports the role of genetic and immunologic factors. There are no proven medical therapies that alter the natural course of the disease. Thus, liver transplantation is the only available treatment for patients with advanced PSC, with excellent outcomes in this population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a small percentage of patients, CSPH in PSC (in analogy to PBC) may occur early in the disease course, i.e. even in people with PSC with F2 or F3 fibrosis in the absence of full-blown histologic cirrhosis.250”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [250]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729
Diagnosis and Management of Primary Sclerosing Cholangitis
Chapman, R. W., Fevery, J., Kalloo, A. N., Nagorney, D. M., Boberg, K. M., Shneider, B. L., & Gores, G. J. (2009) · Hepatology · doi:10.1002/hep.23294 · Cited by 1,230
Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy
Ghazale, A., Chari, S. T., Zhang, L., Smyrk, T. C., Takahashi, N., Levy, M. J., Topazian, M. D., Clain, J. E., Pearson, R. K., Petersen, B. T., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.12.009 · Cited by 890
Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.
Broomé, U., Olsson, R., Lööf, L., Bodemar, G., Hultcrantz, R., Danielsson, A., Prytz, H., Sandberg–Gertzén, H., Wallerstedt, S. M., & Lindberg, G. (1996) · Gut · doi:10.1136/gut.38.4.610 · Cited by 816
PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis
Loftus, E. V., Harewood, G. C., Loftus, C. G., Tremaine, W. J., Harmsen, W. S., Zinsmeister, A. R., Jewell, D. A., & Sandborn, W. J. (2005) · Gut · doi:10.1136/gut.2004.046615 · Cited by 777
High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis
Lindor, K. D., Kowdley, K. V., Luketic, V. A. C., Harrison, E. M., McCashland, T., Befeler, A. S., Harnois, D., Jorgensen, R., Petz, J., Keach, J., et al. (2009) · Hepatology · doi:10.1002/hep.23082 · Cited by 720
Hepatic and extrahepatic malignancies in primary sclerosing cholangitis
Bergquist, A., Ekbom, A., Olsson, R., Kornfeldt, D., Lööf, L., Danielsson, Å., Hultcrantz, R., Lindgren, S., Prytz, H., Sandberg-Gertzén, H., et al. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00288-4 · Cited by 717
Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis
Wiesner, R. H., Grambsch, P. M., Dickson, E. R., Ludwig, J., MacCarty, R. L., Hunter, E. B., Fleming, T. R., Fisher, L. D., Beaver, S. J., & LaRusso, N. F. (1989) · Hepatology · doi:10.1002/hep.1840100406 · Cited by 641
Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic review
Boonstra, K., Beuers, U., & Ponsioen, C. Y. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.10.025 · Cited by 632
Soetikno, R. M., Lin, O. S., Heidenreich, P. A., Young, H. S., & Blackstone, M. O. (2002) · Gastrointestinal Endoscopy · doi:10.1067/mge.2002.125367 · Cited by 623
Research works printed but not linked: 1
- Karlsen, 2009, The Nordic liver transplant registry, Annu Rep, 2012, 2009
Cited by
Sorted by citations
Cancers Complicating Inflammatory Bowel Disease
Beaugerie, L., & Itzkowitz, S. H. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1403718 · Cited by 692
Axelrad, J. E., Lichtiger, S., & Yajnik, V. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i20.4794 · Cited by 431
EASL Clinical Practice Guidelines on sclerosing cholangitis
Chazouilleres, O., Beuers, U., Bergquist, A., Karlsen, T. H., Levy, C., Samyn, M., Schramm, C., & Trauner, M. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.05.011 · Cited by 419
Chronic ulcerative colitis and colorectal cancer
Rogler, G. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.07.032 · Cited by 421
Guy, J. E., & Peters, M. G. (2013) · Europe PMC (PubMed Central) · Cited by 244
The role of ERCP in benign diseases of the biliary tract
Chathadi, K. V., Chandrasekhara, V., Acosta, R. D., Decker, G. A., Early, D. S., Eloubeidi, M. A., Evans, J. A., Faulx, A. L., Fanelli, R. D., Fisher, D. A., et al. (2015) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2014.11.019 · Cited by 179
Palmela, C., Peerani, F., Castañeda, D., Torres, J., & Itzkowitz, S. H. (2017) · Gut and Liver · doi:10.5009/gnl16510 · Cited by 180
Outcomes in liver transplantation: Does sex matter?
Sarkar, M. A., Watt, K. D. S., Terrault, N. A., & Berenguer, M. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.11.023 · Cited by 116
Cancer in Inflammatory Bowel Disease
Faye, A. S., Holmer, A. K., & Axelrad, J. E. (2022) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2022.05.003 · Cited by 87
Sørensen, J. Ø., Nielsen, O. H., Andersson, M., Ainsworth, M. A., Ytting, H., Bélard, E., & Jess, T. (2017) · Liver International · doi:10.1111/liv.13548 · Cited by 85
Malignancies in Inflammatory Bowel Disease
Greuter, T., Vavricka, S. R., König, A. O., Beaugerie, L., Scharl, M. M., & on behalf of Swiss IBDnet, A. O. W. G. O. T. S. S. O. G. (2020) · Digestion · doi:10.1159/000509544 · Cited by 78
Singh, S., Varayil, J. E., Loftus, E. V., & Talwalkar, J. A. (2013) · Liver Transplantation · doi:10.1002/lt.23741 · Cited by 78
Self-citationERCP-related adverse events in patients with primary sclerosing cholangitis
Navaneethan, U., Jegadeesan, R., Nayak, S., Lourdusamy, V., Sanaka, M. R., Vargo, J. J., & Parsi, M. A. (2014) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2014.06.030 · Cited by 72
Primary sclerosing cholangitis associated with inflammatory bowel disease
Rossi, R. E., Conte, D., & Massironi, S. (2015) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000532 · Cited by 66
Ananthakrishnan, A. N., Cagan, A., Gainer, V. S., Cheng, S., Cai, T., Szolovits, P., Shaw, S. Y., Churchill, S. E., Karlson, E. W., Murphy, S. N., et al. (2014) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2014.01.019 · Cited by 58
Complex Network of NKT Cell Subsets Controls Immune Homeostasis in Liver and Gut
Marrero, I., Maricic, I., Feldstein, A. E., Loomba, R. S., Schnabl, B., Rivera–Nieves, J., Eckmann, L., & Kumar, V. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02082 · Cited by 55
Bowlus, C. L., Eksteen, B., Cheung, A., Thorburn, D., Moylan, C. A., Pockros, P. J., Forman, L., Dorenbaum, A., Hirschfield, G. M., Kennedy, C., et al. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000153 · Cited by 47
Review of primary sclerosing cholangitis with increased IgG4 levels
Manganis, C., Chapman, R. W., & Culver, E. L. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i23.3126 · Cited by 49
Wang, X., & Tian, Z. (2018) · Frontiers of Medicine · doi:10.1007/s11684-017-0584-x · Cited by 43
A Comprehensive Approach to Pouch Disorders
Quinn, K. P., Lightner, A. L., Faubion, W. A., & Raffals, L. E. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy267 · Cited by 42
Long-term outcomes of autoimmune pancreatitis
Ikeura, T., Miyoshi, H., Shimatani, M., Uchida, K., Takaoka, M., & Okazaki, K. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i34.7760 · Cited by 39
Axelrad, J. E., Hashash, J. G., & Itzkowitz, S. H. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.03.032 · Cited by 35
Risk of diabetes and cardiovascular disease in patients with primary sclerosing cholangitis
Ludvigsson, J. F., Bergquist, A. M., Montgomery, S., & Bahmanyar, S. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.11.017 · Cited by 32
Secondary sclerosing cholangitis: mimics of primary sclerosing cholangitis
Ludwig, D. R., Anderson, M., Itani, M., Sharbidre, K., Lalwani, N., & Paspulati, R. M. (2022) · Abdominal Radiology · doi:10.1007/s00261-022-03551-z · Cited by 32
Kanda, Y., Osaki, M., & Okada, F. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040867 · Cited by 32
Quinn, K. P., Tabibian, J. H., & Lindor, K. D. (2016) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2016.1263681 · Cited by 29
Matsushita, H., Miyake, Y., Takaki, A., Yasunaka, T., KOIKE, K. A., Ikeda, F., Shiraha, H., Nouso, K., & Yamamoto, K. (2014) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12711 · Cited by 27
Lee, H.-J., Park, J., Han, Y. M., Gil, H. K., Kim, J.-H., Chang, J. Y., Jeong, M., Go, E., & Hahm, K. B. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2016.1103179 · Cited by 27
Isa, F., Turner, G., Kaur, G., Kyte, D. G., Slade, A. L., Pankhurst, T., Kerecuk, L., Keeley, T., Ferguson, J., & Calvert, M. (2018) · Health and Quality of Life Outcomes · doi:10.1186/s12955-018-0951-6 · Cited by 25
Axelrad, J. E., & Shah, S. C. (2020) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284820920779 · Cited by 23
IgG4‐Related Sclerosing Cholangitis: Rarely Diagnosed, but not a Rare Disease
Dražilová, S., Veselíny, E., Lenártová, P. D., Drazilova, D., Gazda, J., Grgurević, I., Janíčko, M., & Jarčuška, P. (2021) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2021/1959832 · Cited by 22
Primary sclerosing cholangitis in children versus adults: lessons for the clinic
Adike, A., Carey, E. J., & Lindor, K. D. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2018.1521719 · Cited by 21
Primary Immunodeficiency and the Gut
Schwimmer, D., & Glover, S. C. (2019) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2019.02.004 · Cited by 21
Nivolumab-Induced Secondary Sclerosing Cholangitis with Deterioration Despite Immunosuppression
Anderson, B. J., & Dawe, D. E. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.04.023 · Cited by 21
Inhibition of microRNA-24 increases liver fibrosis by enhanced menin expression in Mdr2 −/− mice
Hall, C. M., Ehrlich, L., Meng, F., Invernizzi, P., Bernuzzi, F., Lairmore, T. C., Alpini, G. D., & Glaser, S. S. (2017) · Journal of Surgical Research · doi:10.1016/j.jss.2017.05.020 · Cited by 20
Irlès‐Depé, M., Roullet, S., Neau‐Cransac, M., Dumortier, J., Dharancy, S., Houssel‐Debry, P., Boillot, O., Chiche, L., Laurent, C., Laharie, D., et al. (2020) · Liver Transplantation · doi:10.1002/lt.25838 · Cited by 20
de Souza, M. H. G., Lima, L. C. V., Al‐Sharif, L., & Huang, D. Q. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.09.037 · Cited by 19
Voigtländer, T., Wlecke, J., Negm, A. A., Lenzen, H., Manns, M. P., & Lankisch, T. O. (2014) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000042 · Cited by 18
Primary sclerosing cholangitis in common variable immune deficiency
Mahdavinia, M., Mirsaeidi, M. S., Bishehsari, F., & McGrath, K. G. (2015) · Allergology International · doi:10.1016/j.alit.2014.09.003 · Cited by 17
Imaging of autoimmune biliary disease
Yeh, M. J., Kim, S. Y., Jhaveri, K. S., Behr, S. C., Seo, N., & Yeh, B. M. (2016) · Abdominal Radiology · doi:10.1007/s00261-016-0903-8 · Cited by 16
Vannas, M. J., Boyd, S., Färkkilä, M. A., Arola, J., & Isoniemi, H. (2016) · Liver International · doi:10.1111/liv.13276 · Cited by 16
Biron, A., Beaugerie, L., Chazouillères, O., & Kirchgesner, J. (2022) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17123 · Cited by 15
Wan, P., Zhang, J., Long, X., Li, Q., Xu, N., Zhang, M., Chen, X., Han, L., & Xia, Q. (2014) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000070 · Cited by 15
The Liver in Pediatric Gastrointestinal Disease
Vo, H. D., Xu, J., Rabinowitz, S. S., Fisher, S. E., & Schwarz, S. M. (2014) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000444 · Cited by 15
Solid extraintestinal malignancies in patients with inflammatory bowel disease
Mala, A., Foteinogiannopoulou, K., & Κoutroubakis, I. E. (2021) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v13.i12.1956 · Cited by 14
Bile duct basement membrane thickening in primary sclerosing cholangitis
Colling, R. T., Verrill, C. L., Fryer, E., Kartsonaki, C., Wang, L. M., Chapman, R. W., Rajabally, N., & Fleming, K. (2015) · Histopathology · doi:10.1111/his.12857 · Cited by 14
Merli, A., Vieujean, S., Massot, C., Blétard, N., Calvo, F. Q., Baiwir, D., Mazzucchelli, G., Servais, L., Wéra, O., Oury, C., et al. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa168 · Cited by 15
Kalman, R. S., Hartshorn, K. L., & Farraye, F. A. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000211 · Cited by 13
Poetter‐Lang, S., Messner, A., Bastati, N., Ringe, K. I., Ronot, M., Venkatesh, S. K., Ambros, R., Kristic, A., Korajac, A., Dovjak, G. O., et al. (2023) · European Radiology · doi:10.1007/s00330-023-09915-3 · Cited by 13
Dohan, A. J. J., Faraoun, S. A., Barral, M., Guerrache, Y., Boudiaf, M., Dray, X., Hoeffel, C. C., Allez, M., Farges, O., Beaugerie, L., et al. (2015) · Diagnostic and Interventional Imaging · doi:10.1016/j.diii.2015.02.009 · Cited by 13
Liver transplant in primary sclerosing cholangitis: Current trends and future directions
Shah, Y. R., Nombera-Aznaran, N., Guevara-Lazo, D., Martinez, E. C., Tiwari, A., Kanumilli, S., Shah, P. C., Pinnam, B. S. M., Ali, H., & Dahiya, D. S. (2023) · World Journal of Hepatology · doi:10.4254/wjh.v15.i8.939 · Cited by 15
Geramizadeh, B., Ghavvas, R., Kazemi, K., Shamsaeefar, A., Nikeghbalian, S., & Malek‐Hosseini, S. A. (2015) · Hepatitis Monthly · doi:10.5812/hepatmon.33626 · Cited by 12
Gender Mainstreaming and Transplant Surgery
Dobrindt, E. M., Krebs, I., Langelotz, C., Pratschke, J., & Rau, B. (2016) · Visceral Medicine · doi:10.1159/000446357 · Cited by 12
Mark‐Christensen, A., Erichsen, R., Veres, K., Laurberg, S., & Sørensen, H. T. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz199 · Cited by 11
Practical Guide for Radiological Diagnosis of Primary and Secondary Sclerosing Cholangitis
Pria, H. R. F. D., Torres, U. S., Faria, S. C., Velloni, F. G., Caiado, Â. H. M., Tiferes, D. A., & D’Ippolito, G. (2022) · Seminars in Ultrasound CT and MRI · doi:10.1053/j.sult.2022.06.007 · Cited by 10
Saadi, M., Yu, C. H., & Othman, M. O. (2014) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2013.00021 · Cited by 10
Autoimmune Diseases of the Biliary Tract
Lee, C. W., & Ronnekleiv‐Kelly, S. M. (2019) · Surgical Clinics of North America · doi:10.1016/j.suc.2018.11.003 · Cited by 10
An update on treatment options for primary sclerosing cholangitis.
Iravani, S., Moghadam, A. D., Razavi-Khorasani, N., Moazzami, B., Beirami, A. D., Mansour-Ghanaei, A., Majidzadeh‐A, K., Mehrvar, A., Khoshdel, A., Toosi, M. N., et al. (2020) · Gastroenterology and hepatology from bed to bench. · Cited by 10
Dekkers, N., van Meeteren, M. W., Wolterbeek, R., Sarasqueta, A. F., Laleman, W., Inderson, A., Desschans, B., van Hoek, B., Korkmaz, K. S., Vermeire, S., et al. (2020) · Digestive and Liver Disease · doi:10.1016/j.dld.2020.02.006 · Cited by 9
Lin, W., Gerullat, L., Braadland, P. R., Fournier, A., Hov, J. R., & Globisch, D. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202318579 · Cited by 9
Benign Biliary Strictures and Leaks
Deviere, J. M. E. (2015) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2015.06.004 · Cited by 9
Brzački, V., Jovanović, A., Rančić, A., Tešić-Rajković, S., Petrović, G., Nagorni, I., Stojanović, M., Stanković, E., & Momčilović, S. (2025) · Cells · doi:10.3390/cells14191521 · Cited by 8
Approach to Jaundice and Abnormal Liver Function Test Results
Habib, S., & Shaikh, O. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-37591-7.00007-0 · Cited by 8
Primary Sclerosing Cholangitis
(2017) · Elsevier eBooks · doi:10.1016/b978-0-323-44307-4.50045-2 · Cited by 7
Hong, R., Li, Z., Li, M., & Dai, Y. (2025) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848241311165 · Cited by 7
Diverse Subsets of γδT Cells and Their Specific Functions Across Liver Diseases
Zhan, C., Peng, C., Wei, H., Wei, K., Ou, Y., & Zhang, Z. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062778 · Cited by 9
Ursodeoxycholic Acid for the Treatment of Liver Diseases
Wang, J.-Y., & Wu, S.-D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804274-8.00055-2 · Cited by 8
Influence of Sex in the Development of Liver Diseases
Zhang, J., Zhang, N., Lyu, Y., & Zhang, X. (2025) · Seminars in Liver Disease · doi:10.1055/a-2516-0261 · Cited by 7
Liu, P. M. F., Silva, A. C. S. E., Silva, S. L. C., de Aquino, D. J. Q., Fagundes, E. D. T., de Miranda, D. M., & Ferreira, A. R. (2016) · Gastroenterology Research and Practice · doi:10.1155/2016/3905240 · Cited by 6
A morphometric study of the hepatic arterioles in end-stage primary sclerosing cholangitis
Fiel, M. I., Sima, H. R., Azarian, A., & Schiano, T. D. (2014) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-014-1680-9 · Cited by 5
Role of Endoscopy in Primary Sclerosing Cholangitis
Koro, N. S., & Alkaade, S. (2013) · Current Gastroenterology Reports · doi:10.1007/s11894-013-0361-1 · Cited by 5
Alvarenga, L. R., Sandy, N. S., Gomez, G. S., Hessel, G., Tommaso, A. M. A. D., & Bellomo‐Brandão, M. A. (2021) · Arquivos de Gastroenterologia · doi:10.1590/s0004-2803.202100000-41 · Cited by 5
Yadlapati, S., & Judge, T. A. (2021) · Cureus · doi:10.7759/cureus.19922 · Cited by 5
Costamagna, G., Boškoski, I., & Familiari, P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-48109-0.00043-2 · Cited by 5
Suskind, D. L., Wu, B., Braly, K., Pacheco, M. C., Wahbeh, G. T., & Lee, D. Y. (2018) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001966 · Cited by 6
Cytopenias in Autoimmune Liver Diseases—A Review
Abdulrasak, M., Someili, A. M., & Mohrag, M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14051732 · Cited by 4
Endoscopic Retrograde Cholangiopancreatography: A Review of Technique and Clinical Indications
Wanis, K. N. (2014) · Journal of Gastrointestinal & Digestive System · doi:10.4172/2161-069x.1000208 · Cited by 4
Ahrar, H., Jafarpishe, M. S., Hekmatnia, A., Solouki, R., & Emami, M. H. (2014) · Europe PMC (PubMed Central) · Cited by 4
Role of Endoscopic Retrograde Cholangiopancreatography in Benign Biliary Diseases
Kamani, L. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.108525 · Cited by 3
Primary sclerosing cholangitis: an update
Feuerstein, J. D., & Tapper, E. (2013) · Cited by 3
Polanco, N. A. P., Cottone, C., & Bhamidimarri, K. R. (2020) · Current Hepatology Reports · doi:10.1007/s11901-020-00518-w · Cited by 3
Kanel, G. C. (2017) · doi:10.1002/9781118894903.ch4 · Cited by 3
Kowdley, K. V., Safer, R., Gomel, R., Hatchett, J., Walmsley, M., Burman, J. A., Weinbaum, S., Goldsmith, K., Nunes, T. F., Terner-Rosenthal, J., et al. (2026) · Hepatology Communications · doi:10.1097/hc9.0000000000000904 · Cited by 2
Yadlapati, S. (2021) · Advanced Research in Gastroenterology & Hepatology · doi:10.19080/argh.2021.17.555954 · Cited by 2
Hatami, B., Pasharavesh, L., Sharifian, A., & Zali, M. R. (2023) · Gastroenterology and hepatology from bed to bench. · doi:10.22037/ghfbb.v16i2.2589 · Cited by 2
Metabolomics Approach to Identify Biomarkers of Epidemic Diseases
Mina, P. R. (2023) · Springer eBooks · doi:10.1007/978-3-031-39094-4_4 · Cited by 2
Tfifha, M., Kamoun, T., Mama, N., Mestiri, S., Hassayoun, S., Zouari, N., Jemni, H., & Abroug, S. (2019) · The Turkish Journal of Pediatrics · doi:10.24953/turkjped.2019.06.012 · Cited by 2
Primary Sclerosing Cholangitis
Shah, S. K., & Silveira, M. G. (2018) · Springer eBooks · doi:10.1007/978-3-319-98506-0_18 · Cited by 2
Yu, P.-J., Ho, C., Hsiao, C., Wu, Y., Ho, M., Lee, P., & Hu, R. (2023) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002516 · Cited by 1
Lin, W., Gerullat, L., Braadland, P. R., Fournier, A., Hov, J. R., & Globisch, D. (2024) · Angewandte Chemie · doi:10.1002/ange.202318579 · Cited by 1
OLSZEWSKA, A., MATYJA, K., Berner, A., Stencel, K., Stelmaszak, K., MARCZYK, K., Polak, P., PĘKAŁA, M., POLASZEK, M., & Bogowska, M. (2024) · Journal of Education Health and Sport · doi:10.12775/jehs.2024.60.003 · Cited by 1
Secondary sclerosing cholangitis: an unusual presentation of leptospirosis
Aponso, T., Wanninayake, W. M. D. A. S., Wijesinghe, I. P., Jayasekara, N., Iddamalgoda, W., & Wanasinghe, W. M. M. A. (2025) · Tropical Medicine and Health · doi:10.1186/s41182-025-00700-0 · Cited by 1
Moniruzzaman, M., Shah, A., Fairlie, T., Keely, S., Burns, G. L., Talley, N. J., & Holtmann, G. (2025) · United European Gastroenterology Journal · doi:10.1002/ueg2.70115 · Cited by 1
Abdulla, A. H., Sheikhnoor, A., Ferrao, K., Stiles, L. I., & Mehta, K. J. (2026) · Clinical and Experimental Medicine · doi:10.1007/s10238-026-02102-w · Cited by 1
Stepanov, Y. М., Kosynska, S. V., & Pavlenko, O. V. (2018) · Pathologia · doi:10.14739/2310-1237.2018.1.127703 · Cited by 1
Primary Sclerosing Cholangitis Overlapping with IBD
Sabino, J., tenHove, J., & Torres, J. (2019) · Springer eBooks · doi:10.1007/978-3-030-11446-6_16 · Cited by 1
Kim, W. K. (2022) · Springer eBooks · doi:10.1007/978-981-19-0120-1_14 · Cited by 2
Primary Sclerosing Cholangitis: A Clinical Update
Sundaram, S., & Jearth, V. (2019) · European Medical Journal · doi:10.33590/emj/10313809 · Cited by 1
Ryan, T., & Segal, J. P. (2024) · Frontline Gastroenterology · doi:10.1136/flgastro-2023-102600 · Cited by 1
Benign biliary strictures: Endoscopic management
Boškoski, I., & Costamagna, G. (2016) · Techniques in Gastrointestinal Endoscopy · doi:10.1016/j.tgie.2016.07.002 · Cited by 1
Metadata
- Authors
- Singh, S., & Talwalkar, J. A.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Talwalkar, Jayant A.
- ORCID
- Singh, Siddharth
- Venue
- Clinical Gastroenterology and Hepatology
- Publisher
- Elsevier BV
- Published
- 2013-08
- Volume
- 11
- Issue
- 8
- Pages
- 898-907
- ISSN
- 1542-3565 (ISSN-L)
- PMC
- PMC3692584
- OpenAlex
- W2076789082
- Cited by
- 119
- References
- 114
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 6 · 2023: 9 · 2022: 8 · 2021: 5 · 2020: 8 · 2019: 7 · 2018: 10 · 2017: 11 · 2016: 9 · 2015: 13 · 2014: 13 · 2013: 6
- FWCI
- 1.74
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Gastroenterology and Hepatology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK056924)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Keywords
- primary sclerosing cholangitis, bile duct inflammation, liver fibrosis, portal hypertension, hepatobiliary cancer, cholangiocarcinoma, gallbladder cancer, inflammatory bowel disease, colorectal cancer risk, liver transplantation, prognosis, pathogenesis, immune-mediated liver disease
- MeSH terms
- Bile Ducts, Gallbladder Neoplasms, Humans, Hypertension, Portal, Liver Neoplasms, Prognosis, Cholangitis, Sclerosing, Liver Transplantation, Liver Failure, Cholangiocarcinoma
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
